Hot-Topics Pipelines 
pharmaphorum
AUGUST 16, 2021
The Oxford-based company had originally hoped to raise $50 million from the series B, and the scale of the financing is further evidence that repurposing psychedelic compounds as potential therapies for neuro-psychiatric disorders is a hot topic in biopharma.
pharmaphorum
MARCH 19, 2021
Gain Therapeutics has priced its initial public offering, raising more than $40 million for its computational drug discovery platform and pipeline of drugs for diseases associated with protein misfolding. . The shares began trading on the Nasdaq yesterday under the symbol ‘GANX’, closing at $11.20
pharmaphorum
APRIL 20, 2022
The potential of CRISPR technology has been a hot topic in the industry ever since it was first developed, but as trials progress further into the clinic, what therapeutic areas could be set to benefit? Ben Hargreaves takes a look at why oncology could be one of the major beneficiaries of a growing pipeline of CRISPR therapeutics.
Expert insights. Personalized for you.
135 
Let's personalize your content